Oxford Immunotec
Andrew Rogers is a Senior Scientist with experience in developing molecular-based tests for bacterial and yeast/fungi identification from clinical samples. Andrew has also led projects in biomarker discovery, genomics, and gene expression using microarray technology. With a PhD in Microbiology from the University of Nottingham and a BSc in Human Biology from Aston University, Andrew has a strong background in the medical and biological sciences.
Oxford Immunotec
Oxford Immunotec, Inc., located in the United States, offers an FDA approved Tuberculosis test, T-SPOT.TB, for detection of TB infection; More accurate than tb skin tests